Neurowyzr

Neurowyzr operates at the intersection of digital diagnostics, clinical neuroscience, and preventative brain health. Its stated scope is broader than a standalone cognitive-testing application: the company combines a medical-grade Digital Brain Function Screen with a neuroscience clinic and consulting services covering detection, diagnosis, therapy, monitoring, and prevention. That integrated model may distinguish it from narrower digital cognitive-assessment providers, while its gamified assessments are intended to reduce friction for patients and make repeated screening more accessible. The company also emphasizes analytics, artificial intelligence, and clinical evidence, creating a proposition that spans software-enabled assessment and human-led care. With $2.1 million in seed funding and an estimated employee band of 11 to 50, Neurowyzr remains an early-stage participant rather than a scaled healthcare platform. Its Singapore base and recognition in Forbes Asia’s 2024 100 to Watch list support regional visibility, but expansion and defensibility remain unconfirmed.

Neurowyzr was founded in 2019 and has developed from a brain-health concept into a multi-part offering that includes digital assessment, clinical services, and consulting. The major disclosed inflection point was the $2.1 million seed round announced on Aug 14, 2023, co-led by Jungle Ventures and Peak XV Partners. That financing appears to have supported the company’s ability to position the Digital Brain Function Screen alongside a neuroscience clinic and broader brain-health services, although the record does not identify specific post-financing launches or revenue results. A second visibility milestone came on Nov 12, 2024, when Neurowyzr was included among Singapore companies on Forbes Asia’s 100 to Watch list. The company’s current employee band is estimated at 11 to 50, but there is no time-series hiring data to establish whether headcount is expanding, stable, or contracting. Web activity signals and a small mobile-app footprint suggest digital distribution, yet they do not establish commercial scale. The trajectory therefore shows early capital formation and ecosystem recognition, with limited evidence of scale acceleration after 2024.